Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMYOLEV)

Drug Name
D-ribosylnicotinate Drug Info
Synonyms
D-ribosylnicotinate; Beta-D-ribosylnicotinate; Nicotinate ribonucleoside; Nicotinate ribose; Nicotinate riboside; Nicotinic Riboside; Nicotinic acid ribonucleoside; beta-D-Ribosylnicotinate; nicotinic acid ribose; nicotinic acid riboside; ribosylnicotinate; 1-(; 1-(beta-D-ribofuranosyl)pyridinium-3-carboxylate; 1-Pentofuranosylpyridin-1-ium-3-carboxylate; 17720-18-2; 3-Carboxy-1-; A-D-ribofuranosylpyridinium Inner Salt; A-d-ribofuranosyl)pyridinium-3-carboxylate; AC1L4P1J; AC1Q22CH; CHEBI:58527; DTXSID20938912; SCHEMBL20152239
Cross-matching ID
PubChem CID
161233
ChEBI ID
CHEBI:58527
CAS Number
CAS 17720-18-2
TTD Drug ID
DMYOLEV
INTEDE Drug ID
DR2074

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DME
Drug Status:
Approved Drug(s)
Investigative Drug(s)
Download the Complete Related Drug List
Drug(s) Metabolized By Nicotinamide riboside kinase 2 (NRK2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Uridine DMQTREB Depression 6A70-6A7Z Approved [1]
Tiazofurin DM5JWV9 Solid tumour/cancer 2A00-2F9Z Approved [1]
cytidine DMK0W8E Discovery agent N.A. Investigative [1]
Drug(s) Metabolized By Nicotinamide riboside kinase 1 (NRK1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Uridine DMQTREB Depression 6A70-6A7Z Approved [1]
Tiazofurin DM5JWV9 Solid tumour/cancer 2A00-2F9Z Approved [1]
cytidine DMK0W8E Discovery agent N.A. Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Nicotinamide riboside kinase 1 (NRK1) DENV24I NRK1_HUMAN Substrate [1]
Nicotinamide riboside kinase 2 (NRK2) DE8DJ3N NRK2_HUMAN Substrate [1]

References

1 Nicotinamide riboside kinase structures reveal new pathways to NAD+. PLoS Biol. 2007 Oct 2;5(10):e263.